Co-administration of a charge-conversional dendrimer enhances antitumor efficacy of conventional chemotherapy.

Cao, Jun; Wang, Chenhong; Guo, Leijia; Xiao, Zhiyong; Liu, Keliang; Yan, Husheng

Cao, Jun; Wang, Chenhong; Guo, Leijia; Xiao, Zhiyong; Liu, Keliang; Yan, Husheng.

Affiliation

Cao J; Key Laboratory of Functional Polymer Materials (Ministry of Education), College of Chemistry, Nankai University, Tianjin 300071, China.
Wang C; Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Guo L; Key Laboratory of Functional Polymer Materials (Ministry of Education), College of Chemistry, Nankai University, Tianjin 300071, China.
Xiao Z; Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Liu K; Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Yan H; Key Laboratory of Functional Polymer Materials (Ministry of Education), College of Chemistry, Nankai University, Tianjin 300071, China; Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin 300071, China. Electronic address: yanhs@nankai.edu.cn.

Eur J Pharm Biopharm ; 127: 371-377, 2018 Jun.

Article de En | MEDLINE | ID: mdl-29499301

Sujet(s)
Mots clés

Charge conversion; Chemotherapy potentiator; Dendrimer; Drug delivery; pH responsive

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dendrimères / Antinéoplasiques Limites: Animals / Female / Humans Langue: En Journal: Eur J Pharm Biopharm Sujet du journal: FARMACIA / FARMACOLOGIA Année: 2018 Type de document: Article Pays d'affiliation: Chine Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google